D-0781-2016 Class II Terminated

Recalled by AstraZeneca Pharmaceuticals LP — Wilmington, DE

Recall Details

Product Type
Drugs
Report Date
March 30, 2016
Initiation Date
February 5, 2016
Termination Date
June 20, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
148,331 Inhalers

Product Description

Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.

Reason for Recall

Defective Delivery System: Some units have actuation counters set to a number other than 60.

Distribution Pattern

US: Nationwide Including Puerto Rico

Code Information

Lot # 1144394, Expiry: 04/2018; Lot # 1145539, Expiry: 04/2018; Lot # 1145868, Expiry: 05/2018.